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Abstract
Background and Aims: Iridoid glycosides (IG), the major active fraction of F. syringae leaves has been demonstrated to have
strong anti-inflammatory properties to ulcerative colitis (UC) in our previous study. The aim of this study was to investigate
whether IG modulates the inflammatory response in experimental colitis at the level of NF-kB signal pathway and epithelial
cell apoptosis.
Methods: UC in rats was induced by administration with dextran sulfate sodium (DSS) in drinking water. The inflammatory
damage was assessed by disease activity index (DAI), macroscopic findings, histology and myeloperoxidase (MPO) activity.
The effect of IG on pro-inflammatory cytokines TNF-a, IL-8, COX-2 and regulatory peptide TGF-b1 was measured. Epithelial
cell apoptosis and the protein and mRNA expressions of Fas/FasL, Bcl-2/Bax, caspase-3, NF-kB p65, IkBa, p-IkBa and IKKb
were detected by TUNEL method, immunohistochemistry, Western blotting and real-time quantitative PCR, respectively.
Results: IG significantly ameliorated macroscopic damage and histological changes, reduced the activity of MPO, and
strongly inhibited epithelial cell apoptosis. Moreover, IG markedly depressed TNF-a, IL-8, COX-2 and TGF-b1 levels in the
colon tissues in a dose-dependent manner. Furthermore, IG significantly blocked of NF-kB signaling by inhibiting IkBa
phosphorylation/degradation and IKKb activity, down-regulated the protein and mRNA expressions of Fas/FasL, Bax and
caspase-3, and activated Bcl-2 in intestinal epithelial cells.
Conclusions: These results demonstrated for the first time that IG possessed marked protective effects on experimental
colitis through inhibition of epithelial cell apoptosis and blockade of NF-kB signal pathway.
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Introduction
Ulcerative colitis (UC), the major forms of inflammatory bowel
disease (IBD), is an immunologically mediated chronic intestinal
disorder. The disease commonly follows a chronic relapsing course
with clinically quiescent periods followed by bouts of severe
intestinal inflammation, which are characterized by abdominal
pain, diarrhea, rectal bleeding and weight loss [1]. Furthermore,
prolonged and chronic UC may progress to colorectal cancer [2].
Despite substantial progress has been made in the treatment of UC
along the immune and inflammatory pathways, no definitive
therapies with a nonrelapsing cure rate are available for this
disorder until now, and limiting drug-induced toxicity is a
continuous challenge [3,4]. Traditional therapeutic modalities
are used for UC including anti-inflammatory therapy (5-
aminosalicylic acid and corticosteroids), some immunomodulators
(azathioprine, 6-mercaptopurine and cyclosporine) [5]. However,
these drugs have demonstrated unsatisfactory results and the
recrudescence rates of IBD are rather high. Therefore, it is
challenging to develop new and specific therapies for the treatment
of IBD.
Although the exact etiology and pathogenesis of IBD are not
fully defined up to now, a growing body of work suggests that
inflammatory response and intestinal epithelial cell (IEC) apoptosis
mainly participate in the pathogenesis of IBD [1,6]. The abnormal
mucosal immune and inflammation responses in IBD are
predominantly characterized by increased synthesis of pro-
inflammatory cytokines, the activation of neutrophils, and
enhanced formation of reactive oxygen and nitrogen species.
These mediators can activate the nuclear factor kappa B (NF-kB)
pathway, modulating a number of different steps in the
inflammatory cascade [7,8]. These include production of pro-
inflammatory cytokines such as tumour necrosis factor alpha
(TNF-a), interleukin-1b (IL-1b), interferon-c (INF-c), IL-6, IL-8,
and IL-12 in different cell-types, degranulation of neutrophils, as
well as the expression of important inflammatory proteins such as
cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase
(iNOS) [9–11]. Therefore, imbalance between pro-inflammatory
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expression, plays an important role in the modulation of intestinal
immune system and contributes to the inflammatory cascade in
the pathological process of colitis [12]. On the other hand, the
pathogenesis of UC involved in the abnormality of apoptosis.
Growing evidence indicated that the nuber of apoptotic epithelial
cells is increased during active UC, which may lead to an
alteration of the epithelial barrier function resulting in pathogenic
microorganism infiltration [6,13]. It has been reported that
different mechanisms are involved in the induction of apoptosis.
One pathway is mediated by the interaction between cell surface
death receptor Fas and its specific ligand FasL. Such an interaction
leads to the formation of the death-inducing signalling complex
and activation of caspase-8 and caspase-10, two initiator caspases
that in turn activate downstream effector caspase-3 [14]. Another
is mediated by proapoptotic signals at the mitochondria level
including members of Bcl-2 family and caspase-9 [15]. Trans-
forming growth factor-b1 (TGF-b1) counteracts TNF-a and
regulates cFLIP protein acting as a negative regulator of
caspase-8 and thereby inhibits Fas-mediated apoptosis in mucosal
inflammation that is essential for wound healing and tissue repair
[16,17]. Importantly, TGF-b is known to be one of the most
potent cytokines in the regulation of mediators (TGF-a, EGF, IL-
1, IL-2, IFN-c) and plays an important role in the prevention of
intestinal epithelial destruction [18,19]. TGF-b1 expression is
increased parallel to the increase of pro-inflammatory cytokine
secretion in patients with UC and Crohn’s disease (CD) [20]. NF-
kB mediates the IL-1b induction of TGF-b1 gene expression and
NF-kB RelA antisense oligonucleotides suppress TGF-b1 mRNA
expression [21]. There are also studies implying that successful
treatment of UC-related mucosal injury results in decrease of
TGF-b1 level in plasma and intestinal mucosa [22]. In this regard,
the regulation of inflammatory response and IEC apoptosis may
be a promising therapeutic modality for UC.
NF-kB signal pathway plays a pivotal role in regulating the
production of pro-inflammatory cytokines and apoptosis of IEC in
UC, which contribute to cytokine-mediated mucosal tissue damage,
leading to a breakdown in the mucosal barrier [23,24]. Increased
NF-kB activation has been detected in the mucosa of patients with
IBD and in a murine colitis model, and inhibition of NF-kB with a
specific p65 antisense oligonucleotide is effective in preventing
experimental models of IBD and efficiently down-regulates cytokine
production by intestinal macrophages from Crohn’s disease (CD)
patients [25,26]. NF-kB can be activated by diverse stimuli (e.g.,
pro-inflammatory cytokines, microbes and microbial products, and
oxidative stress) that signal its activation through the catalytic IkB
kinase b (IKKb) [23,27]. IKKb phosphorylates NF-kB-bound IkBs
in the cytoplasm and targets their degradation, thereby leading to
subsequent release of NF-kB dimmers, which then translocate from
the cytoplasm to the nucleus and activate the transcription of
multiple kB-dependent target genes [28], including pro-inflamma-
torycytokines (TNF-a, IL-1a, IL-6, IL-8, IL-12, MCP-1,interferon-
c), death and survival proteins (Bcl-2, Bcl-xl, Bcl-xs, Bax, p53, Myc,
Fas), intercellular adhesion molecules (ICAM), COX-2 and iNOS
[29,30]. Growing evidence reveals that the inhibition of NF-kB
activity by either directed blockade of RelA (p65) or suppression of
IkBa degradation or IKKb activity may lead to alleviating the
severity of intestinal inflammation [26,31]. Therefore, the modu-
lation of NF-kB signaling pathway could be the main target for the
treatment of IBD.
Folium syringae leaves have been used in herbal medicines to treat
inflammatory intestinal disease such as acute enteritis and bacillary
dysentery in China for a long time. Iridoid glycosides (IG) is the
main active fraction extracted from F. syringae leaves, with high
content of syringopicroside [32]. Although our previous studies
indicate that IG exert conspicuous anti-inflammatory effects on UC
in vivo by scavenging reactive oxygen species (ROS) and inhibiting
relative pro-inflammatory cytokines [33]. The molecular mecha-
nisms of IG involved in protection against UC are still not entirely
clear. In the present study, we further explored whether its
mechanism was associated with modulating NF-kB signaling
pathway and IEC apoptosis. The protective effects of IG on
dextran sulfate sodium (DSS)-induced colitis were assessed by
macroscopic score and histological analysis as well as by
determination of inflammation markers such as MPO activity and
themRNA expressionsofpro-inflammatorycytokinessuchasTNF-
a and IL-8. The activity of COX-2 and TGF-b1 were also
evaluated. In order to elucidate the probable mechanisms of IG in
ameliorating inflammatory injury in experimental colitis, the anti-
inflammatory effects of IG on activation change of NF-kB signaling
pathway and the relative expressions of serial genes involved in IEC
apoptosis were evaluated by immunohistochemistry, western
blotting and real-time quantitative PCR, respectively.
Materials and Methods
Animals and reagents
Male Sprague-Dawley rats weighing 200–220 g, were supplied
by Slaccas Laboratory Animal Co. Ltd. (Shanghai, China). The
rats were maintained in standard cages in a controlled room
(temperature 24–25uC, humidity 70–75%, lighting regiment of
12L/12D) and fed with standard rodent diet. All animal exper-
iments were approved under animal protocol number SCXK
(Zhe) 2008-0033 by Zhejiang Medical Laboratory Animal Admi-
nistration Committee. Experimental animals were treated accord-
ing to Guideline of Laboratory Animal Care from Chinese
Ministry of Science and Technology in 2006 (Available from:
http://www.most.gov.cn/fggw/zfwj/zfwj2006/200609/t2006093
0_54389. htm).
F. syringae leaves were collected in Heilongjiang Province,
China, in September 2008. Voucher specimens (No. 20080916) of
this material was identified by Professor Jianming Wang, and
deposited at Heilongjiang University of Chinese Medicine. The
iridoid glycosides fraction was purified using D-141 macroporous
adsorption resin column from F. syringae leaves based on previously
described procedures [32]. The content of syringopicroside in the
iridoid glycosides fraction reached 55.74%.
No specific permits were required for the described field studies.
The field studies did not involve endangered or protected species.
Salicylazosulfapyridine (SASP) was purchased from Sine Pharma-
ceutical Co. Ltd. (Shanghai, China). DSS was provided by MP
Biomedicals (M.W.=36–50 kDa, USA). Apoptosis detection kit was
supplied by Boster Bio-engineering limited company (Wuhan, China).
Bax kit was purchased from Santa Cruz Biotechnologies (USA). The
primers for real-time quantitative RT-PCR were synthesized from
GeneCore Biotechnologies Co. Ltd. (Shanghai, China).
Induction of colitis and experimental design
Rats (n=60) were adapted for 1 week and randomly assigned to
6 groups (n=10). Drinking water containing 4% dextran sulfate
sodium (DSS) was provided for 1 week to induce colitis [34].
Following 7 days of DSS administration, IG (80, 160 and 240 mg/
kg) were suspended in 0.9% saline solution and administered twice
daily by oral gavage for 14 days, respectively. Positive control
group received SASP in a dose of 150 mg/kg twice daily. Normal
and model groups received the vehicle in a comparable volume
(10 ml/kg body weight), respectively.
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damage
The rats were checked daily for body weight, behavior, stool
consistency and the presence of gross blood in stool. At the end of
the experimental period, rats were sacrificed using an overdose of
anesthetic. The entire colon was excised from the cecum to the
anus and opened longitudinally. Colon length as an indirect
marker of inflammation was measured. Macroscopic damage was
assessed using a validated scoring system with slight modifications
[35,36]. The numerical rating score were as follows: 0, no
inflammation; 1, local hyperemia without ulcers, and/or stool
consistency; 2, ulceration without hyperemia; 3, ulceration and
adhesions at one site; 4, two or more sites of inflammation and
ulceration extending .1 cm; and 5, ulceration extending more
than 2 cm.
Colonic tissues were fixed in 4% buffered paraformaldehyde,
then dehydrated through graded concentrations of ethanol,
subsequently embedded in paraffin, and finally sectioned in
4 mm thick sections. After dewaxing and rehydration, the sections
were stained with hematoxylin-eosin (H&E) according to standard
procedures for histological evaluation. The colonic pieces were
collected from inflamed portions after samples were taken for
histological examination and frozen in liquid nitrogen to quantify
biochemical parameters.
Determination of myeloperoxidase (MPO) activity
Myeloperoxidase (MPO) activity was determined with the O-
dianisidine method [37], using a MPO detection kit (Nanjing
Jiancheng Bioengineering Institute). Colon tissues were washed in
ice-cold physiological saline to remove fecal residues and weighed
on analytical scale, then homogenized three times in 9 volumes of
ice-cold physiological saline. The MPO activity was measured with
a spectrophotometer (756pc Shanghai Spectrum Instrument Co.
Ltd., China) by absorbance at 460 nm. MPO activity was defined
as the quantity of enzyme degrading 1 mmol of peroxide per
minute at 37uC and was expressed in units per gram weight of wet
tissue.
Immunohistochemical analysis
Colon tissues were fixed in 4% buffered paraformaldehyde and
4 mm sections were prepared from paraffin-embedded tissues.
After deparaffinization in xylene and rehydration in a series of
graded alcohol, endogenous peroxidase was quenched with 3.0%
hydrogen peroxide in methanol for 30 min. For the heat
rehabilitation of antigen, slides were immersed in 10 mmol/L
citrate buffer (pH 6.0) and performed by microwave for
10 minutes, then cooled for 20 minutes. Slides were incubated
with polyclonal primary antibody of Bax (diluted to 1:100)
overnight at 4uC. The sections were washed three times with
phosphate-buffered saline (PBS) and incubated with polyclonal
rabbit anti-mouse biotinylated secondary antibody (Dako, CA,
USA) at room temperature for 30 min. After washing with PBS,
the sections were incubated with 3, 39-diaminobenzidine solution
(Sigma, St Louis, MO, USA) until a brown reaction product could
be visualized. Sections were washed with PBS and stained with
haematoxylin. Then the sections were dehydrated with increasing
concentration of ethanol, mounted with neutral gum, and
observed under an Olympus BH-2 microscope.
Analysis of intestinal epithelial cell apoptosis
Apoptotic epithelial cells in colonic tissue were analyzed using
the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-
biotin nick end labeling (TUNEL) assay according to the
manufacturer’s instruction. TUNEL-positive nuclei were clearly
identified as brown-stained nuclei, which indicated the presence of
DNA fragmentation due to apoptosis. TUNEL-positive cells were
determined by observing 1000 cells in randomly selected fields.
Western blot analysis
Colon tissues were pounded to pieces in liquid nitrogen, then
disrupted by homogenization on ice in hypotonic lysis buffer
containing: 20 mmol/L N-2-Hydroxyethylpiperazine-N9-29-
ethanesulfonic Acid (HEPES) pH 7.8, 1.5 mmol/L MgCl2,
420 mmol/L NaCl, 1 mmol/L ethylenediamine tetraacetic acid
(EDTA), 1 mmol/L ethylene glycol bis (2-aminoethyl ether)-
N,N,N9N9-tetraacetic acid (EGTA), 1 mmol/L dithiothreitol
(DTT), 0.5 mmol/L phenylmethyl sulfonylfluoride (PMSF),
15 mg/ml trypsin inhibitor, 3 mg/ml pepstatin, 2 mg/ml leupeptin,
40 mmol/L benzidamin, 1% Nonidet P-40 and 20% glycerol.
Homogenates were centrifuged at 4uC (12,000 g, 15 min). The
supernatants were collected as nuclear extracts in aliquots and
stored at 280uC for western blotting analysis. Protein concentra-
tions were determined by Bradford assay.
Equal amounts of protein (40 mg/lane) were separated on 10%
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to a nitrocellulose membrane. Membranes
were blocked in 5% skim milk dissolved in 10 mmol/L Tris-HCl,
pH 7.5, 100 mmol/L NaCl and 0.1% Tween-20, and incubated
with anti-NF-kBp65, anti-IkBa, anti-IKKb, anti-b-actin (Santa
Cruz Biotechnology) and anti-phosphserine IkBa polyclonal
antibodies (Cell signaling, Beverly, USA) at dilution of 1:500,
1:500, 1:500, 1:1000 and 1:500, respectively. The membranes
were washed three times for 15 min with Tween-20/Tris-buffered
saline (TTBS) and incubated with horseradish peroxidase-
conjugated secondary antibodies (diluted to 1:2000, Santa Cruz
Biotechnology). Blots were again washed with TTBS, and then
developed by enhanced chemiluminescence detection regents
(ECL, Amersham). The protein bands were quantified by the
average ratios of integral optic density (IOD) following normal-
ization to the housekeeping gene.
Real-time quantitative RT-PCR
Total RNA was isolated from colonic tissue using Trizol
reagent (Invitrogen, Carlsbad, CA, USA). For each sample, 1 mg
of RNA was reverse-transcribed (RT) using AMV reverse
transcriptase (Promega), 1 mmol/L deoxyribonucleotide triphos-
phate (dNTP) (GibcoBRL), and oligo (dT12–18)0 . 5 mg/ml
(GibcoBRL). ABI TaqMan 26PCR Master mix of primers
(Applied Biosystems, Foster City, CA, USA) and TaqMan MGB
probes (FAM dye-labeled) were used for the target genes and pre-
developed 18S rRNA (VIC-dye-labeled probe). Real-time RT-
PCR was performed using an ABI Prism 9700 sequence detection
system (Applied Biosystems, Foster City, CA) with specific
primers for rat NF-kBp65, IkBa,I K K b,T N F - a, IL-8, TGF-b1,
COX-2, Fas, FasL, Bcl-2, Caspase-3. b-actin was used as a house-
keeping gene. All primers were designed by Primer Premier 5.0
software (Molecular Biology Insights, USA). The primer sequenc-
es used in PCR amplification are shown in Table 1. Thermal
cycler parameters were as follows: one cycle of 50uC for 2 min,
95uC for 10 min, and 40 cycles of denaturation (95uC, 30 s) and
combined annealing/extension (60uC, 30 s). Duplicate cycle
threshold (CT) values were analyzed in Microsoft Excel using
the comparative CT (
DDCT) method as described by the
manufacturer. The amount of target (2
2DDCT) was obtained by
normalizing it to an endogenous reference (18S rRNA) and
relative to a calibration curve.
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The results were expressed as the mean 6 SD. SPSS 16.0
statistical software was used for the analysis. Differences between
groups were compared using one way analysis of variance and
two-tailed Student’s t test. P,0.05 was considered significant.
Results
Iridoid glycosides ameliorate DSS-induced colitis
The therapeutic efficacy of IG on experimental colitis was
assessed by body weight change, colon length, disease activity
index (DAI), histological analysis and MPO activity. Severe drug-
induced colitis was observed from the 4th day after DSS
administration, which was characterized by obvious hyperemia,
edema, stool consistency and ulceration (Fig. 1C). The animals of
normal group averagely increased (13.8962.01)% in the body
weight, whereas a dramatic body weight loss and shortened colon
length accompanied with obvious diarrhea in DSS group was
observed as a result of the colitis, and was maintained during the
experimental period (Fig. 1A and B). Administration of SASP
effectively suppressed body weight loss and colon shortening.
However, treatment of IG (80–240 mg/kg) could significantly
reverse the changes of two parameters induced by DSS in a dose-
dependent manner. Histological studies showed that inflamed
tissue had marked necrosis of colonic mucosa, hyperemia and
adhesions to adjacent bowel wall. Additionally, MPO activity was
significantly increased after DSS administration compared with
normal group. Administration with SASP could improve the acute
inflammatory response. Nevertheless, treatment with IG dose-
dependently inhibited these pathological symptoms and MPO
activity with lower DAI (Fig. 1C, D, E and F). In particular, IG
(240 mg/kg) had a better therapeutic effect than SASP. This result
strongly suggested that the inhibition of neutrophil infiltration was
a mechanism for the protective effects of IG in experimental
colitis.
Effect of iridoid glycosides on key inflammatory cytokine
expression
In order to test whether treatment with IG may modulate the
inflammatory process through the regulation of the expressions of
key NF-kB-dependent cytokines, the mRNA levels of TNF-a, IL-
8, TGF-b1 and COX-2 in colonic tissue were examined by real-
time quantitative RT-PCR. As shown in Fig. 2, the mRNA levels
of TNF-a, IL-8, TGF-b1 and COX-2 in DSS model group
showed a significantly high expression compared with normal
control group (P,0.01). In contrast, administration of SASP
obviously decreased the expressions of TNF-a, IL-8, TGF-b1 and
COX-2 mRNA. Especially, IG treatment inhibited the expressions
of the four inflammatory genes in a dose-dependent manner to
some degree (Fig. 2 A, B, C and D). Maximum inhibition effect
was observed with IG at a dose of 240 mg/kg.
Effect of iridoid glycosides on IEC apoptosis
To study whether experimental colitis is associated with IEC
apoptosis and the effect of IG on IEC apoptosis, we measured
TUNEL staining in colonic tissues. As shown in Fig. 3B, few
apoptotic cells were observed in normal group, whereas colon
tissues demonstrated a marked appearance of dark brown
apoptotic cells and intercellular apoptotic fragments after
treatment with DSS (P,0.01, Fig. 3C). In contrast, administration
of SASP obviously decreased the number of apoptotic epithelial
cells and apoptotic fragments (Fig. 3D). Treatment with IG
remarkably reduced the percentages of TUNEL-positive cells in a
dose-dependent manner (P,0.01, Fig. 3E, F and G). In particular,
IG in a dose of 240 mg/kg was the most effective in suppressing
IEC apoptosis.
Effect of iridoid glycosides on the expressions of serial
genes involved in IEC apoptosis
As it could be informed from Fig. 4A, the mRNA levels of Fas
and FasL in normal group were very low. Both of their expression
levels in the colonic epithelia of DSS-induced model group were
significantly higher than those of normal group (p,0.01). In
contrast, administration of SASP effectively inhibited FasL mRNA
expression (p,0.05), whereas the mRNA level of Fas had no
significant difference compared with DSS group (p.0.05).
Treatment with IG dose-dependently decreased the mRNA
expressions of Fas and FasL. Especially, IG in a dose of
240 mg/kg was the most effective in down-regulating the mRNA
levels of Fas and FasL.
Immunohistochemistry and real-time PCR results showed that
the protein expression of Bax in DSS group was distinctly elevated
compared with normal group (p,0.01, Fig. 5), whereas no
significant difference of Bcl-2 mRNA level was found between
DSS group and normal group (p.0.05, Fig. 4B). SASP obviously
suppressed Bax protein expression level. But it had no effect on the
mRNA expression of Bcl-2. Nevertheless, IG treatment signifi-
cantly diminished the induced upregulation of Bax protein
expressions in a dose-dependent manner. IG (240 mg/kg) was
the most effective in reducing the protein expression of Bax
Table 1. Sequences of the amplification primers used in the
real-time RT-PCR.
mRNA Species Oligonucleotides (59R39)
NF-kBp65 forward ACCTGGAGCAAGCCATTAGC
reverse CGGACCGCATTCAAGTCATA
IkBa forward TGGAGCCGACCTCAATAAACC
reverse TGCGACTGTGAACCACGATG
IKKb forward AGCTCTGGAACCTCCTGAAGA
reverse AGCTCCAGTCTAGGGTCGTGA
TNF-a forward GCCAATGGCATGGATCTCAAAG
reverse CAGAGCAATGACTCCAAAGT
IL-8 forward CTCCAGCCACACTCCAACAGA
reverse CACCCTAACACAAAACACGAT
TGF-b1 forward CGCAACAACGCAATCTATG
reverse CCCTGTATTCCGTCTCCTT
COX-2 forward ACTACGCCGAGATTCCTGACA
reverse ACTGATGAGTGAAGTGCTGGG
Fas forward AACTTCTATTGCAATGCTTCTCTCTGT
reverse CAAGGCTCAAGGATGTCTTCAA
FasL forward CACCAACCACAGCCTTAGAGTATCA
reverse ACTCCAGAGATCAAAGCAGTTCCA
Bcl-2 forward TCAAACAGAGGTCGCATGCT
reverse CATCTGCACACCTGGATCCA
Caspase-3 forward GAGGCCGACTTCCTGTATGC
reverse TGACCCGTCCCTTGAATTTC
b-actin forward TGGAATCCTGTGGCATCCATGAAAC
reverse TAAAACGCAGCTCAGTAACAGTCCG
doi:10.1371/journal.pone.0024740.t001
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PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24740Figure 1. Iridoid glycosides (IG) ameliorate the clinical, macroscopic and histological features of acute colitis model. Colitis was
induced by 4% DSS in drinking water. Rats were administrated p.o. at different dose of IG 80, 160 and 240 mg/kg twice daily for 14 days after
administration of DSS. Allratswere sacrificed on the 14 day after the first IG administration. Theseverity of colonic injury andthe clinical evaluation were
monitored by weight changes (A), colon length (cm) (B) histological analysis (C), macroscopic signs (D: a, normal group; b, DSS group; c, SASP group; d,
highdose group of IG 240 mg/kg), disease activity index (E) andMPOactivity (U/g tissue) (F).Representative macroscopic andhistological analysis of rat
colonic tissue in normal group, DSS group and high dose group of IG (240 mg/kg) (C and D) were shown in this figure. SASP (150 mg/kg p.o.) was used
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regulate the mRNA level of Bcl-2 (P,0.01, Fig. 4B).
As shown in Fig. 4C, the Caspase-3 mRNA expression of
colonic epithelia cells in DSS group was markedly increased
compared with normal group (p,0.01). Administration of SASP
effectively inhibited Caspase-3 mRNA expression (p,0.01). The
Caspase-3 mRNA level of colonic epithelia in IG group was
significantly decreased in a dose-dependent manner compared to
that in DSS group. Furthermore, the effect of IG in a dose of
240 mg/kg was prior to that of SASP (p,0.05).
Our study suggested that one mechanism underlying the
protective effect of IG involved in the regulation of serial genes
associated with IEC apoptosis in experimental colitis.
Effect of iridoid glycosides on NF-kB signal pathway
NF-kB activation can be regulated at several steps, including the
nuclear translocation of its p65/RelA component and phosphor-
ylation/degradation of IkBa [28]. In addition, IkBa phosphory-
lation is mediated by the activation of IKKb unit of the IKK
complex in numerous cell systems [23]. To further determine the
impact of IG on cytokine-induced signal transduction in
experimental colitis, we investigated the expression levels of
representative upstream and downstream signal proteins involved
in NF-kB activation using real-time PCR and Western blotting
analysis. A significant increase in the mRNA and protein
expressions of NF-kBp65 and IKKb were observed in colonic
epithelia cells of DSS-induced model group (p,0.01, Fig. 6A, C
Figure 2. Effect of iridoid glycosides on the mRNA expressions of TNF-a, IL-8, TGF-b1 and COX-2 in DSS-induced colitis. Rats were
administered with IG (80, 160, 240 mg/kg/day p.o.) for 14 days. SASP (150 mg/kg/day p.o.) was used as a positive control. The mRNA expressions of
(A) TNF-a, (B) IL-8, (C) TGF-b1 and (D) COX-2 were determined using real-time quantitative PCR. The data are expressed as the mean 6 standard
deviation (Mean 6 SD). DD p,0.01 vs normal group; * p,0.05, ** p,0.01 vs DSS group; w p,0.05, ww p,0.01 vs SASP group.
doi:10.1371/journal.pone.0024740.g002
as apositivecontrol. IGadministrationdose-dependentlydiminishedtheseparameters.Thedataareexpressedasthemean 6standarddeviation(Mean
6 SD). DD p,0.01 versus normal group; * p,0.05, ** p,0.01 versus DSS group; w p,0.05, ww p,0.01 versus SASP group.
doi:10.1371/journal.pone.0024740.g001
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IkBa were distinctively induced in colonic epithelia cells of DSS-
induced rats compared with normal group (p,0.01, Fig. 6B and
D). In contrast, administration of SASP obviously reduced NF-
kBp65 and IKKb expressions in DSS-induced colitis, and the
phosphorylation/degradation of IkBa were effectively suppressed,
too. In accordance with the data presented in Fig. 6A and D, IG
inhibited NF-kB nuclear translocation as indicated by dose-
dependently decreasing p65/RelA expression and IkBa degrada-
tion in colonic epithelia cells compared with that in DSS group.
However, IG (240 mg/kg) exerted the optimum effect in
suppressing NF-kBp65 level and IkBa degradation. On the other
hand, IG significantly blocked IkBa phosphorylation and IKKb
activity in a dose-independent manner (p,0.05, Fig. 6C and D).
IG (160 mg/kg) showed the maximum inhibition effect.
These results indicated that IG markedly blocked NF-kB
signaling pathway in experimental colitis by inhibiting its binding
to target DNA and suppressing IkBa phosphorylation/degrada-
tion and IKKb activity in IEC.
Discussion
The present study was undertaken to investigate the potential
anti-inflammatory and anti-apoptosis effects of IG on experimen-
tal colitis induced by DSS and the mechanisms involved. NF-kB
signaling pathway regulates multiple kB-dependent genes involved
Figure 3. Effect of iridoid glycosides on intestinal epithelial cells apoptosis. Apoptotic cells in the colon tissues were detected using TUNEL
assay. Cells with nuclei that stained dark brown were considered to be TUNEL-positive. (A) Apoptosis index (%); (B) Normal group, (C) DSS Model
group; (D) SASP group; (E) IG 80 mg/kg, (F) IG 160 mg/kg and (G) IG 240 mg/kg (original magnification 6400). Apoptosis index indicated that the
percentage of TUNEL-positive cells significantly decreased in a dose-dependent manner after treatment with IG compared with the DSS Model group.
Data were expressed as mean 6SD (each group, n=10). DD p,0.01 versus normal group; * p,0.05, ** p,0.01 versus DSS group; w p,0.05 versus
SASP group.
doi:10.1371/journal.pone.0024740.g003
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ideal target for the molecular therapy of UC [23,38]. Therefore,
understanding the molecular mechanisms involved in this pathway
is an essential step towards countering the damaging effects of pro-
inflammatory mediators and cell apoptosis in IBD. In our previous
study, IG, the main active fraction extracted from F. syringae leaves,
has been known to possess strong anti-inflammatory activities and
acts as an inhibitor for NF-kBp65 and oxidative-free radicals in
experimental colitis [33]. However, the mechanism whereby IG
inhibits NF-kB activity and IEC apoptosis has not been
investigated. On the basis of the above, we hypothesized that IG
might also modulate IkB/NF-kB pathway in DSS-induced colitis,
through which it could inhibit intestinal inflammation and IEC
apoptosis in vivo.
To confirm the validity of these hypotheses, first, we
investigated the effect of IG on NF-kB-mediated inflammatory
cytokine expression in DSS-induced colitis, which represents
several characteristics resembling human UC. Recent studies have
demonstrated increased production of pro-inflammatory cytokines
including TNF-a, IL-1b, IL-6, IL-8, ICAM-1 and COX-2 in IBD
that are known to play a key role in the modulation of intestinal
immune system [29,33]. TNF-a released from macrophages in the
early inflammatory response plays an important role in experi-
mental colitis and it is likely the regulator key of the inflammatory
cascade in IBD. IL-6 and IL-8 could stimulate neutrophil
chemotaxis and relate to the presence of necrosis in the colon
which led to tissue destruction. COX-2 is an important NF-kB-
dependent mediator, in both of acute murine colitis and colitis-
related cancer. The COX-2 level was increased in IBD and in
colon cancer [39,40]. Therefore, blockade of these inflammatory
mediators can offer an alternative therapy for UC. However, it is
insufficient for achieving the optimal therapeutic effects only to
block individual factors in a multifactorial inflammatory disease.
Actually, individual factor such as cytokine or COX-2 only
represents a downstream target, whereas NF-kB is just the final
common pathway of the inducible expression of these pro-
inflammatory genes or rate-limiting step in the inflammatory
cascade of UC [33,38]. Increased NF-kB activation has been
detected in the intestinal lamina propria of patients with IBD, and
in a acute murine colitis model [26,29]. The cytokine-induced
IkB/NF-kB signaling cascade is complex, involving the participa-
tion of multiple kinases and adapter proteins. The critical rate-
limiting step in the activation of the NF-kB pathway is the catalytic
IkB kinase (IKK) [41]. Cytokine (TNF-a and IL-1b) or bacterial
product signaling converge on the IKK complex to trigger IkBa
phosphorylation and ultimately NF-kB activity in numerous cell
systems [4,42]. Activation of NF-kB then upregulates the
expression of numerous kB-dependent pro-inflammatory genes
involved in intestinal inflammation, including TNF-a, IL-6, IL-8,
ICAM-1, iNOS, and COX-2 [29,43]. IKK is made up of two
kinases, IKKa and IKKb. Whereas IKKa is activated by an only
limited set of stimuli, IKKb activation occurs upon receptor-
mediated stimulation by a broad set of microbial or host-derived
ligands [44]. Gene depletion studies have demonstrated that
IKKb, but not IKKa, plays an essential role in NF-kB activation
[41]. In order to achieve the optimal therapeutic effects, the
application of a therapeutic strategy that interferes with NF-kB
pathway (the upstream target) in the cascade of inflammation,
namely, the blockade of simultaneously the expression of multiple
pro-inflammatory genes, might be more effective than suppressing
individual factor in treatment of UC. To demonstrate the effect of
IG on NF-kB pathway, we utilized real-time quantitative PCR
and Western blotting to determine NF-kBp65 level, IKKb activity
and IkBa phosphorylation/degradation in colonic tissue. The
Figure 4. Effect of iridoid glycosides on the mRNA expressions
of Fas/FasL, Bcl-2 and Caspase-3 in DSS-induced colitis. Rats
were administered with IG (80, 160, 240 mg/kg/day p.o.) for 14 days.
SASP (150 mg/kg/day p.o.) was used as a positive control. The mRNA
expressions of (A) Fas/FasL, (B) Bcl-2 and (C) Caspase-3 were determined
using real time quantitative PCR. The data are expressed as the mean 6
standard deviation (Mean 6 SD). DD p,0.01 vs normal group;
*p ,0.05, ** p,0.01 vs DSS group; w p,0.05, ww p,0.01 vs SASP
group.
doi:10.1371/journal.pone.0024740.g004
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kBp65 and IKKb were significantly increased in DSS-treated rats.
NF-kBp65 mRNA expression was dose-dependently inhibited and
IKKb decreased dose-independently after administration of IG for
2 weeks. Moreover, DSS strongly induced IkBa phosphorylation
and triggered IkBa degradation in colonic tissue. IG also blocked
IkBa phosphorylation/degradation in a dose-dependent manner.
On the other hand, our study indicated that the levels of TNF-a,
IL-8 and COX-2 in DSS group were increased more distinctly
than normal group and reduced dose-dependently after treatment
with IG in response to NF-kBp65 and IKKb activity. In addition,
the effect of IG at dose of 160 mg/kg and 240 mg/kg were all
prior to SASP. Since the promoter regions of TNF-a, IL-8 and
COX-2 had also been shown to contain consensus binding motifs
for NF-kB. In the present study, we firstly infer that anti-
inflammatory effect of IG may be linked with inhibition of multiple
pro-inflammatory genes through blockade of IkB/NF-kB pathway
in experimental colitis.
Second, to clarify whether IG could modulate IEC apoptosis in
UC in vivo, we investigated the effect of IG on the relative
expression level of a series of apoptosis genes in DSS-induced
colitis. Recent evidence suggests that NF-kB activates the
transcription of many genes capable of regulating apoptosis,
known as the ‘‘cell-death substrates’’ [45]. Fas/FasL is an
important pathway of involved in the induction of epithelial cell
apoptosis in UC [38]. When UC occurred, the expression of FasL
is markedly upregulated on the surface of infiltrating cytotoxic
lymphocytes in active UC and binds the Fas receptor on the
basolateral epithelial membrane [46]. Fas associated death domain
recruits molecules, including procaspase-8, to form the death-
Figure 5. Immunohistochemical localization for Bax. There was few specific expression of Bax in normal tissue (B). Protein expression of Bax
was significantly increased in the epithelial cell, intestine glands and in the inflammatory cells infiltrating in the tissue of model animals (C). Treatment
of SASP (150 mg/kg), Bax protein expression was obviously reduced (D). Administration with IG (80 mg/kg, E; 160 mg/kg, F; 240 mg/kg, G), protein
expression of Bax was effectively inhibited in both mucosa and submucosa in dose-dependent manner (A). Specific expression of Bax was very weak
in the colonic tissue of high-dose group (G). Original magnification 4006.
doi:10.1371/journal.pone.0024740.g005
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its activated form, and the apoptotic cascade ensues, culminating
in the activation of executioner caspase-3 [48]. These interactions
accelerate migration and activity of neutrophils, induce generation
of excessive ROS through NF-kB activation and expression of
FasL, and inhibit immune response at the inflammatory site,
resulting in progressive mucosal lesion of UC [38,46]. Anti-
apoptotic NF-kB target genes include TGF-b1, inhibitors of
apoptosis proteins (IAP), and prosurvial members of the Bcl-2 gene
kindred and so on [19,21]. As Bcl-2 could prolong the life of cells,
it has been generally accepted as an anti-apoptosis gene. The
apoptosis promoting gene Bax is a new member of Bcl-2 gene
kindred, it could form a dimer with Bcl-2 to inhibit its function
[49]. The relative expression ratio of Bax/Bcl-2 determines
whether apoptosis occurs in IEC or not. Excessive expression of
Bax promotes apoptosis, and when the expression of Bcl-2 gained
advantage, the cells would continue to exist [50]. Among the anti-
apoptotic regulatory proteins, TGF-b1 plays especially important
role in the pathogenesis of IBD [51]. TGF-b1 expression can be
induced by pro-inflammatory cytokines, such as IL-1b and TNF-a
[21]. The general opinion showed that TGF-b1 expression in
plasma is increased parallel to the increase in cytokine secretion
due to inflammation in patients with UC and Crohn’s disease
(CD), which can be used as a marker for differential diagnosis of
the active phase of both diseases [52]. Additionally, plasma TGF-
b1 levels are affected by anti-inflammatory drugs such as
glucocorticoid, sulfasalazine and 5-aminosalicylic acid [52,53].
The present study confirmed that DSS-induced colitis leads to a
substantial increase of IEC apoptosis. Meanwhile, the mRNA and
protein expressions of Fas/FasL, Bax and caspase-3 in colonic
epithelia were significantly increased. Activation of these apoptosis
genes increased the number of apoptotic cells, which might be one
of the important mechanisms of colonic pathological changes in
UC. After treatment with IG, activation of Fas/FasL, Bax and
caspase-3 in colonic epithelia were markedly downregulated
compared with DSS group, and the number of apoptosis cells
was also decreased. In addition, our results showed persistent
inflammation resulted in a significant upregulation of TGF-b1
expression and reduction of Bcl-2 expression. IG treatment dose-
dependently reduced TGF-b1 level and increased the mRNA and
protein expression of Bcl-2. These findings demonstrate, for the
first time, the novel protective effects of IG against inflammation in
colon, suggesting a potential clinical value in the treatment of IBD.
Considering that the common effector pathway for regulating
expression of these pro-inflammatory cytokines and apoptosis
genes is IkB/NF-kB transduction system, IG could ameliorate
experimental colitis through the blockade of NF-kB signaling.
Although IG had anti-inflammatory functions through acting
on the IkB/NF-kB pathway, and these effects most probably
Figure 6. Iridoid glycosides blocks NF-kB activation by
inhibiting NF-kB p65 mRNA expression, IkBa phosphoryla-
tion/degradation and IKKb activity in rats with DSS-induced
colitis. The mRNA levels of (A) NF-kB p65, (B) IkB a and (C) IKKb in
colonic tissues were determined using real time quantitative PCR. Total
protein was extracted and examined for NF-kB p65, IkB a, phosphor-IkB
a and IKKb expression by Western blotting (D: a, normal group; b, DSS
group; c, SASP group; d, low dose group of IG 80 mg/kg; e, middle dose
group of IG 160 mg/kg; f, high dose group of IG 240 mg/kg).
Densitometry was made to following normalization to the control
(housekeeping gene). The results are representative of three experi-
ments performed on different samples. Data are expressed as the mean
6 standard deviation (Mean 6 SD). DD p,0.01 vs normal group;
*p ,0.05, ** p,0.01 vs DSS group; w p,0.05, ww p,0.01 vs SASP
group.
doi:10.1371/journal.pone.0024740.g006
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proteins and downstream cytokines of NF-kB in which treatment
of IG were also involved have not been completely demonstrated.
The pro-inflammatory gene transcriptional program mediated by
IkB/NF-kB pathway was induced by toll-like receptor (TLR)
activation and subsequent recruitment of MyD88, followed by
p38-dependent transcriptional activity of the NF-kB complex
leading to induction of target genes, such as TNF-a, IL-27, IL-15,
MMP-9, and VCAM-1 [43,54]. Therefore, our future studies will
investigate these upstream targets and other downstream cyto-
kines, in order to elucidate underlying molecular mechanisms
responsible for the therapeutic effects of IG. Despite we
demonstrated the protective effects of IG on preventing acute
colitis in DSS-induced murine model, which has proven useful for
examining the underlying pathophysiology of IBD. It should be
further validate that whether IG would modulate the inflammation
in different colitis models such as the IL-10 knock-out model and
therapeutic trails for established colitis [43]. In addition, NF-kB
activation has emerged as a hallmark for many human
hematologic malignancies and solid tumors, most commonly
because of persistent activation of the IKK complex [55], and
IKK could be related to the development of colitis-associated
cancer [56]. Intriguingly, a recent study demonstrated that 5-
aminosalicylic acids (5-ASAs) are the most commonly prescribed
anti-inflammatory drugs for IBD. Regular 5-ASA intake may
reduce the risk of colorectal cancer in patients with IBD through
anti-NF-kB action by direct inhibition of IKK [57]. In our study,
IG ameliorates experimental colitis through inhibiting NF-kB
pathway by blockade of IKK activity. In view of this, the effect of
IG on colitis-associated cancer should be further clarified by in vitro
and in vivo studies to support this hypothesis.
In conclusion, the present results demonstrated that IG dose-
dependently ameliorated the severity of DSS-induced colitis. The
possible mechanisms in the protective effect of UC were concluded
that IG could inhibit multiple pro-inflammatory molecules and
modulate serial genes involved in IEC apoptosis through blocking
NF-kB signal pathway. Additionally, numerous studies from
clinical trial as well as animal studies have shown that few toxic
effects or side effects are found with treatment of IG [58].
Recently, antisense oligonucleotide against NF-kB has been
applied in the treatment of UC. However, its price was expensive
and the safety need to be further identified. Therefore, IG, as
natural inhibitor of NF-kB signaling pathway, could be a
promising remedy for the treatment of IBD.
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